Three novel mezigdomide-based triplet therapies were associated with anti-tumor activity in patients with relapsed or refractory multiple myeloma.

Axicabtagene ciloleucel had durable responses, long-term survival, and consistent outcomes in patients with relapsed or ...

Interesting trends were observed in the subgroup analyses of the phase 3 uproleselan study in relapsed or refractory acute ...

Early interventions with daratumumab reduced progression and prolonged overall survival rate in patients with high-risk ...

Elevations in biomarkers such as uterine artery pulsatility index and placental growth factor throughout pregnancy indicate ...

Findings published in Clinical Epigenetics underscore the impact of differentially methylated regions in pregnancy ...

The following is a summary of “Enhancing the effect of rehabilitation on Multiple Sclerosis: A Randomized Clinical Trial ...

The following is a summary of “Disregarded, devalued and lacking diversity: an exploration into women’s experiences with endometriosis. A systematic review and narrative synthesis of qualitative data, ...

The following is a summary of “Explaining persistent physical symptoms to patients in general practice: can tests to measure ...

The following is a summary of “Impact of liquid–liquid phase separation- and immune-related gene signatures on multiple ...

The following is a summary of “Trimetazidine as an adjunct to standard hydration reduces the incidence of contrast-induced acute kidney injury in patients with renal insufficiency undergoing coronary ...

The following is a summary of “Fungal Head and Neck Dermatitis: Current Understanding and Management,” published in the July ...